Perforator Mapping and Optimizing Design of the Lateral Arm Flap
Sponsor
Aswan University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05718635
Collaborator
(none)
30
1
1
32.9
0.9
Study Details
Study Description
Brief Summary
The goal of this clinical trial is to optimize the design of lateral arm flap. Colored duplex will be done for all Participants and compared to intra operative findings.
flap modification (Supra facial) dissection to lateral arm flap will be done and the results will compared to the ordinary method of dissection.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Perforator Mapping and Optimizing Design of the Lateral Arm Flap: Clinical Trial
Actual Study Start Date
:
Oct 1, 2020
Anticipated Primary Completion Date
:
Feb 15, 2023
Anticipated Study Completion Date
:
Jun 30, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: patients candidate for lateral arm flap
|
Diagnostic Test: coloured duplex
colored duplex to locate numbers sites and size of perforators.
Procedure: supra facial dissection
flap raising in supra facial plane
|
Outcome Measures
Primary Outcome Measures
- numbers of perforators [two years]
numbers of perforators in the flap
- site of perforators [two years]
distance from lateral humeral epicondyle in CM
- Size of perforators [two years]
size in millimeter
Eligibility Criteria
Criteria
Ages Eligible for Study:
16 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- adult patients
Exclusion Criteria:
- children injury to pedicle
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Faculty of Medicine | Aswan | Egypt | 81528 |
Sponsors and Collaborators
- Aswan University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Osama Hassan Elbanna,
Associate professor,
Aswan University
ClinicalTrials.gov Identifier:
NCT05718635
Other Study ID Numbers:
- AswanU
First Posted:
Feb 8, 2023
Last Update Posted:
Feb 8, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No